NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Women's Health Law Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Law Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Lil' Drug Store Products



E.U. approves RepHresh Vaginal Gel for prevention and treatment of bacterial vaginosis



February 5th, 2006

RepHresh Vaginal Gel has been approved as a class IIa medical device for the prevention and treatment of bacterial vaginosis (BV) in the E.U.

Its patent-protected formula adheres to the vaginal epithelium for 3 days per use, normalizing pH to a healthy 4.5 or less. BV cannot develop in a vaginal environment with a pH of 4.5 or less. It is the only product of its kind available without a prescription.

Lil' Drug Store Products, headquartered in Cedar Rapids, Iowa, is a privately held company, and is the maker of RepHresh. Lil' Drug Store has its European offices in Maastricht, the Netherlands.

This article was prepared by Women's...


Source: Women's Health Law Weekly (2006-02-05)

NewsRx Passes
Advertisement
More Articles

------------------------
Security by Verisign PR Login